The drug transporter-metabolism alliance: uncovering and defining the interplay.

The drug transporter-metabolism alliance: uncovering and defining the interplay.
复制标题

DOI:
10.1021/mp900253n
复制
发表时间:
2009-11
影响因子:
4.9
通讯作者:
Benet LZ
Benet LZ
中科院分区:
医学2区
文献类型:
--
作者:
Benet LZ

文献摘要

参考文献

被引文献

相似文献

二十年前,人们首次认识到转运蛋白-酶相互作用的重要性及其对药物生物利用度和肝脏处置的影响。在这里,我们回顾了发现和定义这种相互作用的历史,主要重点是我们实验室的研究。我们回顾了20世纪90年代初期的口服生物利用度研究,发现当时市场上的高亲脂性、水溶性差的环孢素制剂并不存在吸收问题,而是存在肠道代谢问题。这导致了对肠道中 CYP3A 和 P-糖蛋白相互作用性质的研究,并使用细胞系统和离体灌注大鼠器官研究对这种相互作用进行了研究。回顾了使用细胞、灌注大鼠肝脏和完整大鼠研究摄取转运蛋白-酶相互作用的研究,随后进行了人类转运蛋白-酶相互作用研究。然后讨论了表征药物转运蛋白-代谢联盟中速率限制过程的工作,最后回顾了需要进一步研究和分析的相互作用领域。
Two decades ago the importance of transporter-enzyme interplay and its effects on drug bioavailability and hepatic disposition were first recognized. Here we review the history of uncovering and defining this interplay with a primary emphasis on studies from our laboratory. We review the early 1990s oral bioavailability studies that found that the highly lipophilic, poorly water soluble cyclosporine formulation on that market at that time did not have an absorption problem, but rather a gut metabolism problem. This led to studies of the interactive nature of CYP3A and P-glycoprotein in the intestine, and investigations of this interplay using cellular systems and isolated perfused rat organ studies. Studies investigating uptake transporter-enzyme interactions using cellular, perfused rat liver and intact rats are reviewed, followed by the human transporter-enzyme interaction studies. Work characterizing the rate limiting processes in the drug transporter-metabolism alliance is then addressed, ending with a review of areas of the interplay that require further studies and analysis.
DOI: 10.1016/0168-3659(95)00147-6
发表时间: 1996-05-01
影响因子: 10.8
作者:
Benet, LZ;Wu, CY;Wacher, VJ
通讯作者: Wacher, VJ
DOI: 10.1038/clpt.1992.171
发表时间: 1992-11-01
影响因子: 6.7
作者:
HEBERT, MF;ROBERTS, JP;BENET, LZ
通讯作者: BENET, LZ
DOI: 10.1177/00912709922007499
发表时间: 1999-01-01
影响因子: 2.9
作者:
Hebert, MF;Fisher, RM;Bekersky, I
通讯作者: Bekersky, I
DOI: 10.1097/00008571-199410000-00003
发表时间: 1994-10-01
期刊: PHARMACOGENETICS
影响因子: --
作者:
KOLARS, JC;LOWN, KS;WATKINS, PB
通讯作者: WATKINS, PB
DOI: 10.1016/s0009-9236(97)90150-8
发表时间: 1997-07-01
影响因子: 6.7
作者:
Floren, LC;Bekersky, I;Hebert, MF
通讯作者: Hebert, MF